People
TC Biopharm doses first three patients in OmnImmune Phase 2b clinical trial
23 November 2022 - TC Biopharm (Holdings) PLC (NASDAQ: TCBP) (NASDAQ: TCBPW), a UK-based clinical stage biotechnology company, announced on Tuesday that it has dosed its first three patients within it...
Congruence Therapeutics names new chief scientific officer
23 November 2022 - Congruence Therapeutics, a Canada-based biotechnology company, announced on Tuesday that it has named Sharath S Hegde, PhD as its new chief scientific officer.Dr Hegde has served as...
Grunenthal names new chief commercial officer
23 November 2022 - Grunenthal, a German, science-based, fully integrated pharmaceutical company, announced on Tuesday that it has named Janneke van der Kamp as its new chief commercial officer effecti...
FogPharma Raises USD 178m in Series D Financing
22 November 2022 - - US-based biopharmaceutical company FogPharma has secured a USD 178m Series D financing, the company said.

The financing round includes new investors ARCH Venture Part...
Purtill Named President and Chief Executive Officer at Invacare
22 November 2022 - - US-based Invacare Corp's (NYSE: IVC) board of directors has named Geoffrey P. Purtill as president and chief executive officer, roles that he has served on an interim basis s...
Medivir names new chief medical officer
22 November 2022 - Medivir AB (Nasdaq Stockholm: MVIR), a Sweden-based pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced on M...